Group 1 - The core index of the CSI Hong Kong Stock Connect Medical Theme Index has shown a decline of 11.89% over the past month, an increase of 13.46% over the past three months, and a year-to-date increase of 8.75% [1] - The index consists of 50 listed companies involved in medical devices, medical services, pharmaceuticals, and biotechnology, reflecting the overall performance of the medical sector within the Hong Kong Stock Connect [1] - The index is based on a starting point of 1000.0 points as of December 31, 2018 [1] Group 2 - The top ten weighted companies in the index include WuXi Biologics (15.72%), JD Health (11.24%), Alibaba Health (7.31%), Sinopharm (5.92%), WuXi AppTec (5.0%), Kingstar BioTech (3.88%), Weigao Group (3.72%), CanSino Biologics (2.43%), MicroPort Medical (2.4%), and Innovent Biologics (2.35%) [1] - The index is exclusively composed of stocks listed on the Hong Kong Stock Exchange, with a 100% allocation [1] Group 3 - The industry composition of the index includes 35.98% in medical services, 30.61% in pharmaceuticals and biotechnology, 12.17% in medical devices, 10.73% in chemical drugs, 10.09% in biological drugs, and 0.42% in traditional Chinese medicine [2] - The index samples are adjusted biannually, with adjustments occurring on the next trading day following the second Friday of June and December each year [2] - In special circumstances, the index may undergo temporary adjustments, such as when a sample company is delisted or undergoes mergers and acquisitions [2]
中证港股通医疗主题指数平盘报收，前十大权重包含威高股份等